Inventor · disambiguated record
Hai Xing Chen
Also filed as: CHEN HAI · CHEN HAI XING
10 granted patents·6 pending applications·109 citations·filing 1999–2022
85Inventor score
Top patents by PatentIndex Score
16 records- 0192US6470170B1System and method for interactive distance learning and examination trainingFiled 2001·Granted Oct 22, 2002·83 cites·24 claims
- 0277US7482122B1Method of signal enhancement for measurement of nucleic acid sequencesCHEN HAI XING·Filed 2005·Granted Jan 27, 2009·2 cites·9 claims
- 0372US9890418B1Method of detecting nucleic acids with enhanced signal using dual-functional capture particlesCHEN HAI XING·Filed 2016·Granted Feb 13, 2018·1 cites·10 claims
- 0470US10781480B1Method of detecting nucleic acids with amplified signal using nanoparticlesACGT CORP·Filed 2018·Granted Sep 22, 2020·3 cites·18 claims
- 0570US7794703B1Method for production and delivery of a protein in vivoCHEN HAI XING·Filed 2009·Granted Sep 14, 2010·1 cites·4 claims
- 0670US7195867B2Method for detection of multiple test materials in a sampleACGT MEDICO INC·Filed 2001·Granted Mar 27, 2007·2 cites·13 claims
- 0760US6337214B1Detection of DNA, RNA and proteins using a test column with two snaresACGT MEDICO INC·Filed 1999·Granted Jan 8, 2002·17 cites·43 claims
- 0855US7544474B2Method for detection of multiple test materials in a sampleACGT MEDICO INC·Filed 2007·Granted Jun 9, 2009·0 cites·25 claims
- 0953US11299548B2Gene combination capable of high-efficiency expression of recombinant human nerve growth factorXINTRUM PHARMACEUTICALS LTD·Filed 2018·Granted Apr 12, 2022·0 cites·6 claims
- 1052US11344008B1Production of human DNaseI in erythrocytes of transgenic non-human mammal using erythroid-specific promoterCHEN HAI XING·Filed 2019·Granted May 31, 2022·0 cites·9 claims
- 1152US2022298215A1Multi-receptor (GLP-1 receptor, GIP receptor, and Gcg receptor) agonist proteinXINTRUM PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 1252US2022298214A1Highly effective blood-glucose-lowering protein drugXINTRUM PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 1351US2021009649A1Intron for increasing expression level of rhngfXINTRUM PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 1450US2022106371A1Modified recombinant human nerve growth factor and method for preparing the sameXINTRUM PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 1548US2022105153A1Use of protein-based long-acting preparation in improving sexual dysfunctionXINTRUM PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 1635US2014035693A1Method and apparatus for implementing high-order modulation schemes using low-order modulatorsLI ZHENG·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hai Xing Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →